The Testosterone Test: Why Hegseth’s Military Hormone Push Exposes a National Health Shift

Pete Hegseth’s recent call for widespread testosterone testing across the U.S. military has ignited a debate that extends far beyond defense policy. At its core, the proposal raises urgent questions about men’s health, medicalization of normal aging, and the cultural framing of vitality in modern America.

While framed as a readiness initiative — ensuring service members are hormonally optimized for duty — the move reflects a deeper national trend: the medicalization and commodification of testosterone. What began as a treatment for clinically diagnosed hypogonadism has evolved into a wellness tool, promoted by clinics, influencers, and direct-to-consumer advertising. Now, as the Pentagon considers routine screening, we must ask: Are we identifying real medical needs, or normalizing hormone enhancement under the guise of performance optimization?

The Military’s Readiness Rationale

Hegseth argues that testosterone levels can impact key domains of military performance: energy, focus, muscle mass, and emotional resilience. Low testosterone, or hypogonadism, is associated with fatigue, reduced motivation, mood disturbances, and impaired recovery — all factors that could affect operational effectiveness in high-stress environments.

In theory, identifying and treating hormonal deficiencies could support force readiness. But implementation is complex. Testosterone fluctuates daily due to sleep, stress, diet, and circadian rhythm. A single blood draw captures only a moment, not a diagnosis. Without clear clinical symptoms, treating borderline levels risks overmedicalizing normal variation.

More critically, testosterone replacement therapy (TRT) carries risks: elevated hematocrit (increasing clot risk), sleep apnea exacerbation, testicular atrophy, and suppression of natural hormone production. These side effects underscore the need for careful clinical oversight — not broad screening without diagnostic rigor.

A National Surge in Hormone Prescriptions

The military’s interest in testosterone testing mirrors a much larger trend in U.S. healthcare. Over the past two decades, TRT prescriptions have risen dramatically, particularly among men under 45 — a demographic not typically prone to age-related hormonal decline.

A 2020 JAMA Internal Medicine study found that TRT use among men aged 18–45 increased by over 400% between 2003 and 2013, far outpacing any rise in diagnosed hypogonadism. Many prescriptions were initiated based on nonspecific symptoms like low energy or reduced libido — symptoms that overlap with depression, poor sleep, sedentary lifestyles, and chronic stress.

Endocrinologists warn that we’re treating physiological responses to modern life as medical conditions. Obesity, lack of physical activity, poor sleep hygiene, and exposure to endocrine-disrupting chemicals (like BPA and phthalates) can all suppress testosterone temporarily. Yet these root causes are often overlooked in favor of pharmaceutical solutions.

The result? A culture where testosterone is marketed not just as a treatment, but as a pathway to strength, youth, and masculinity — a narrative amplified by social media and wellness influencers.

The Military Isn’t Shielded from the Trend

Service members are not immune to these pressures. High operational tempo, irregular schedules, physical strain, and mental health challenges contribute to fatigue and hormonal dysregulation. Some veterans and active-duty personnel have sought TRT privately, citing recovery issues or low energy.

Yet the military health system has traditionally taken a conservative stance on hormone therapy, emphasizing long-term safety and avoiding dependency. The push for testing, therefore, raises concerns about consistency and equity: Will screening lead to uniform access to care? Could hormonal status become a factor in deployment or promotion decisions?

There’s also a risk of creating a two-tier system — where those with access to specialized care receive treatment, while others are left with unaddressed health challenges rooted in systemic issues like sleep deprivation or nutritional deficits.

A Better Approach: Addressing Root Causes

Rather than rushing to test and treat, experts advocate for a more foundational strategy. The military already invests heavily in fitness and resilience programs — these could be expanded to include endocrine health education.

Simple, evidence-based interventions may do more for hormonal balance than prescriptions:

• Sleep hygiene protocols to regulate circadian rhythms and support natural testosterone production
• Nutrition guidance rich in zinc, vitamin D, and healthy fats — all linked to hormonal health
• Stress reduction initiatives that address cortisol’s suppressive effects on the endocrine system
• Screening for mental health conditions like depression and anxiety, which can mimic or exacerbate low testosterone symptoms

For those with clinically significant deficiencies, access to endocrinology specialists and individualized treatment plans should be ensured — but only after thorough evaluation, not routine screening.

Readiness Is More Than a Number

The real issue isn’t whether men have sufficient testosterone — it’s how we define performance and health in high-stakes environments. Readiness isn’t measured in nanograms per deciliter; it’s measured in resilience, decision-making clarity, and sustained physical and mental endurance.

Pete Hegseth’s proposal isn’t inherently flawed, but it must be grounded in clinical evidence, not cultural momentum. Testing should be targeted, diagnostic, and paired with meaningful interventions — not a blanket screening initiative that risks overmedicalizing normal human variation.

The military has an opportunity to lead not just in combat readiness, but in redefining what sustainable health looks like in service. By focusing on prevention, education, and holistic wellness, it can set a standard that goes far beyond the blood lab.